Global Alliance for Patient Access (GAfPA) Miami, 26 May 2018 Chase Martin

GAfPA Introduction The Global Alliance for Patient Access (GAfPA) is a network of physicians and patient advocates with the shared mission of promoting health policy that ensures patient access to appropriate clinical care and approved therapies. GAfPA accomplishes this mission through educating physicians and patients on health policy issues and developing education material and advocacy initiatives to promote informed policymaking. products from recombinent DNA

GAfPA’s Focus International network of physicians and advocates for patient access to approved therapies and appropriate clinical care Policy-focused advocacy with non-profit partners Patient Groups Medical Societies Provide issue briefings, develop educational materials, and support advocacy initiatives Biologics, Pain, Cancer, Inflammation, Respiratory, and Infant Health products from recombinent DNA

2017 Global Activity products from recombinent DNA

In Latin America in 2017 Worked to support interest groups and decision makers in improving the execution of public policies and regulations Continued to strengthen its presence through working with leaders, participating in meetings and forums, and contributing with the formulation of proposals Has established solid bases of collaboration, allowing for implementation of capacity building programs with leaders from different therapeutic areas products from recombinent DNA

Events Rio de Janeiro San Jose products from recombinent DNA

Educational Materials

Policy Papers products from recombinent DNA

“Fast Facts” products from recombinent DNA

Videos products from recombinent DNA

Reports products from recombinent DNA

Blog Publications products from recombinent DNA

Questions?

Global Alliance for Patient Access (GAfPA) Miami, 26 May 2018 Chase Martin